FIELD: chemistry.
SUBSTANCE: invention relates to preparation of new crystalline forms of 4-(cyclopropylmethoxy)-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-methoxypyridine-2-carboxamide of formula 
(I), crystalline forms are designated as crystalline forms o A, B, C, D, E, F, G, H, I, and their application as medicaments.
EFFECT: improved method.
22 cl, 2 tbl, 15 dwg, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCTION OF 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDE-4-PYRIDYL)-5-METHOXYPYRIDINE-2-CARBOXAMIDE | 2013 |
|
RU2635094C2 |
| CRYSTALLINE FORMS OF 3-(2,4-DICHLOROBENZYL)-2-METHYL-N- (PENTYLSULFONYL)-3H-BENZIMIDAZOLE-5-CARBOXAMIDE | 1999 |
|
RU2228931C2 |
| POLYMORPHIC MODIFICATIONS OF N-[(3-FLUORO-4-METHOXYPYRIDINE-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({ 4-[(2-OXOPYRIDINE-1-YL)METHYL]PHENYL} METHYL)PYRAZOLE-4-CARBOXAMIDE AND THEIR SALTS | 2017 |
|
RU2756273C2 |
| CRYSTALLINE FORMS OF GRAPIPRANT | 2015 |
|
RU2638931C1 |
| CRYSTALLINE FORMS OF 1-[(3R,4S)-4-CYANOTETRAHYDROPYRAN-3-YL]-3-[(2-FLUORO-6-METHOXY-4-PYRIDYL)AMINO]PYRAZOLE-4-CARBOXAMIDE | 2019 |
|
RU2828229C2 |
| CRYSTALLINE FORMS OF THE TLR7/TLR8 INHIBITOR | 2019 |
|
RU2792005C2 |
| CRYSTALLINE FORM OF (R)-7-CHLORO-N-(QUINUCLIDIN-3-YL)BENZO[b]THIOPHENE-2-CARBOXAMIDE HYDROCHLORIDE MONOHYDRATE | 2011 |
|
RU2577334C2 |
| CRYSTALLINE FORMS OF N-[4-(CHLORODIFLUOROMETHOXY)PHENYL]-6-[(3R)-3-HYDROXYPYRROLIDIN-1-YL]-5-(1H-PYRAZOL-5-YL)PYRIDINE-3-CARBOXAMIDE | 2020 |
|
RU2836337C2 |
| CRYSTALLINE FORMS OF THE DIHYDROPYRIMIDIN DERIVATIVES | 2013 |
|
RU2646599C2 |
| CRYSTALLINE FORM 1 OF 2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE | 2008 |
|
RU2476434C2 |
